T-2513 is a selective topoisomerase I inhibitor used for its antitumor activity; it stabilizes the topoisomerase I-DNA complex, thereby inhibiting DNA replication and RNA synthesis, leading to cell death; it exhibits broad cytotoxicity against various human tumor cell lines including WiDr, HT-29, SK-BR-3, MKN-1, SK-LU-1, LX-1, KB, and HeLa S3 cells; it demonstrates in vivo antitumor efficacy against Walker-256 carcinoma in rats with an ED50 of 23 mg/kg.